# Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)

> **NCT05354232** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Attention Deficit Disorder
- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DEVICE:** 2 mA transcranial direct current stimulation (tDCS)
- **DEVICE:** 1 mA transcranial direct current stimulation (tDCS)
- **DEVICE:** Sham transcranial direct current stimulation (tDCS)

## Key facts

- **NCT ID:** NCT05354232
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-07-01
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05354232

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05354232, "Home-based Transcranial Direct Current Stimulation (tDCS) for Treatment of Attention-deficit/Hyperactivity Disorder (ADHD)". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT05354232. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*